---
title: "Pravastatin - Familial Type 3 Hyperlipoproteinemia"
sidebar: mydoc_sidebar
permalink: db00175-mesh-d006952-1.html
toc: false 
---


Path ID: `DB00175_MESH_D006952_1`
{% include image.html url="images/db00175-mesh-d006952-1.png" file="db00175-mesh-d006952-1.png" alt="db00175-mesh-d006952-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D017035 | Pravastatin | Drug |
| UniProt:P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Protein |
| GO:0006695 | Cholesterol biosynthetic process | BiologicalProcess |
| MESH:D002784 | Cholesterol | ChemicalSubstance |
| UniProt:P01130 | Low-density lipoprotein receptor | Protein |
| GO:0034383 | Low-density lipoprotein particle clearance | BiologicalProcess |
| MESH:D008077 | Lipoproteins, LDL | ChemicalSubstance |
| MESH:D006952 | Familial type 3 hyperlipoproteinemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Pravastatin | DECREASES ACTIVITY OF | 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase | POSITIVELY REGULATES | Cholesterol Biosynthetic Process |
| Cholesterol Biosynthetic Process | INCREASES ABUNDANCE OF | Cholesterol |
| Cholesterol | POSITIVELY CORRELATED WITH | Familial Type 3 Hyperlipoproteinemia |
| Pravastatin | INCREASES ACTIVITY OF | Low-Density Lipoprotein Receptor |
| Low-Density Lipoprotein Receptor | POSITIVELY REGULATES | Low-Density Lipoprotein Particle Clearance |
| Low-Density Lipoprotein Particle Clearance | DECREASES ABUNDANCE OF | Lipoproteins, Ldl |
| Lipoproteins, Ldl | POSITIVELY CORRELATED WITH | Familial Type 3 Hyperlipoproteinemia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00175](https://go.drugbank.com/drugs/DB00175)
